Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diode lasers in ophthalmology

A P Moriarty1

  • 1Department of Ophthalmology, St Thomas Hospital, London, UK.

International Ophthalmology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

New gallium-aluminium-arsenide (GaAlAs) diode lasers offer affordable, portable ophthalmic laser treatments. Clinical trials show promise for preventing blindness in retinal vascular disease and glaucoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diode laser trabeculoplasty versus argon laser trabeculoplasty in the control of primary open angle glaucoma.

Lasers in medical science·2014
Same author

Enhanced trabeculectomy in a UK district general hospital setting: is selective use of 5-fluorouracil all that is required?

International ophthalmology·2013
Same author

Comment on 'deep sclerectomy with mitomycin C in eyes with failed glaucoma surgery and pseudophakia'.

Eye (London, England)·2012
Same author

Correction of pseudophakic anisometropia in a patient with pseudoexfoliation using an implantable contact lens.

The British journal of ophthalmology·2004
Same author

Biometry surprises.

Journal of cataract and refractive surgery·2003
Same author

Orbital involvement with angiolymphoid hyperplasia with eosinophilia--a benign condition for the practising ophthalmologist to be aware of.

Eye (London, England)·2000
Same journal

Clinical characteristics, management, and visual outcomes of presumed infectious and non-infectious anterior scleritis in a tuberculosis-endemic Indonesian Tertiary Center.

International ophthalmology·2026
Same journal

Assesment of oxidative stress and antioxidant status in pseudoexfoliation syndrome with ocular and systemic comorbidities.

International ophthalmology·2026
Same journal

Surgical outcomes of 27-gauge sutureless versus 23-gauge sutured techniques in congenital cataract surgery: a comparative study.

International ophthalmology·2026
Same journal

Myopia management functional lenses (MMFL): a bibliometric analysis of multidisciplinary perspective and trend insights in the context of vision health.

International ophthalmology·2026
Same journal

Levels of DEL-1 and IL-17 in the aqueous humor of cataract patients with diabetes without diabetic retinopathy.

International ophthalmology·2026
Same journal

Improvement of pattern electroretinogram parameters following glaucoma surgery.

International ophthalmology·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Medical Lasers
  • Biomedical Engineering

Background:

  • Compact gallium-aluminium-arsenide (GaAlAs) laser diodes are now available for clinical ophthalmology.
  • These lasers present advantages such as low cost, reduced running expenses, and portability.
  • The 810 nm emission wavelength may offer specific clinical benefits.

Purpose of the Study:

  • To evaluate the clinical applicability and potential of new GaAlAs diode lasers in ophthalmology.
  • To explore the implications of advanced laser delivery systems for preventing blindness globally.

Main Methods:

  • Clinical trials were conducted to assess the efficacy of GaAlAs lasers in treating retinal vascular disease, performing trabeculoplasty, and cyclophotocoagulation.
  • Investigated novel laser delivery methods including binocular indirect ophthalmoscopes, endolaser, and contact transscleral probes, alongside traditional slit lamp delivery.

Related Experiment Videos

Main Results:

  • Clinical trial outcomes for retinal vascular disease, trabeculoplasty, and cyclophotocoagulation have been encouraging.
  • New laser delivery systems enable treatment in previously inaccessible clinical scenarios.

Conclusions:

  • GaAlAs diode lasers represent a cost-effective and versatile tool for ophthalmic applications.
  • Advanced laser delivery systems hold significant potential for the global prevention of blindness, particularly from glaucoma and retinal vascular diseases.